Potentially, blockage of consensus splice sites or exon splicing enhancers (ESEs) by modified AOs to exclude exons, could be used to partially correct the disease by converting DMD-causing dystrophin transcripts to the milder Becker-like transcripts. This evidence concerns the gene DMD and Duchenne muscular dystrophy.